pravastatin has been researched along with Helicobacter Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, T; Fujiwara, Y; Higuchi, K; Oshitani, N; Shiba, M; Taira, K; Takeuchi, K; Tanigawa, T; Tominaga, K; Watanabe, T; Yamato, M | 1 |
| Hau, P; Koch, HJ; Steinbrecher, A | 1 |
2 other study(ies) available for pravastatin and Helicobacter Infections
| Article | Year |
|---|---|
Anti-inflammatory effects of pravastatin on Helicobacter pylori-induced gastritis in mice.
Topics: Animals; Biomarkers; Disease Models, Animal; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Gene Expression; Helicobacter Infections; Helicobacter pylori; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Interleukin-1beta; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; Pravastatin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |
[Concerning: Devuyst G, Bogousslavsky I. Cholesterol and risk of cerebrovascular accidant: a role for statins?].
Topics: Anticholesteremic Agents; Carotid Stenosis; Cholesterol; Cytochrome P-450 Enzyme System; Drug Interactions; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pravastatin; Risk Factors; Roxithromycin; Stroke | 2000 |